MXPA01003340A - Composiciones farmaceuticas en base a alfa-ciclodextrina para la administracion por via oral de analogos de lh-rh. - Google Patents

Composiciones farmaceuticas en base a alfa-ciclodextrina para la administracion por via oral de analogos de lh-rh.

Info

Publication number
MXPA01003340A
MXPA01003340A MXPA01003340A MXPA01003340A MXPA01003340A MX PA01003340 A MXPA01003340 A MX PA01003340A MX PA01003340 A MXPA01003340 A MX PA01003340A MX PA01003340 A MXPA01003340 A MX PA01003340A MX PA01003340 A MXPA01003340 A MX PA01003340A
Authority
MX
Mexico
Prior art keywords
cyclodextrin
alpha
pharmaceutical compositions
oral administration
analogues
Prior art date
Application number
MXPA01003340A
Other languages
English (en)
Inventor
Jacques Paris
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of MXPA01003340A publication Critical patent/MXPA01003340A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Abstract

La invencion se refiere al uso de una a-ciclodextrina o un derivado de ella para la preparacion de composiciones farmaceuticas para la administracion por via oral de analogos peptidicos de LH-RH. Asimismo, la invencion se refiere a composiciones farmaceuticas orales que contienen analogos peptidicos de LH-RH junto con a-ciclodextrina o un derivado de ella.
MXPA01003340A 1998-09-30 1999-09-23 Composiciones farmaceuticas en base a alfa-ciclodextrina para la administracion por via oral de analogos de lh-rh. MXPA01003340A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98402403A EP0998940A1 (en) 1998-09-30 1998-09-30 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of LH-RH analogues
PCT/EP1999/007389 WO2000018423A1 (en) 1998-09-30 1999-09-23 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues

Publications (1)

Publication Number Publication Date
MXPA01003340A true MXPA01003340A (es) 2004-04-21

Family

ID=8235503

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01003340A MXPA01003340A (es) 1998-09-30 1999-09-23 Composiciones farmaceuticas en base a alfa-ciclodextrina para la administracion por via oral de analogos de lh-rh.

Country Status (28)

Country Link
EP (2) EP0998940A1 (es)
JP (1) JP4485060B2 (es)
KR (1) KR100652457B1 (es)
CN (1) CN1200727C (es)
AR (1) AR023056A1 (es)
AT (1) ATE218358T1 (es)
AU (1) AU756233B2 (es)
BR (1) BR9914125A (es)
CA (1) CA2344470C (es)
CZ (1) CZ302343B6 (es)
DE (1) DE69901721T2 (es)
DK (1) DK1117420T3 (es)
EE (1) EE04872B1 (es)
ES (1) ES2178478T3 (es)
HK (1) HK1042047B (es)
HU (1) HUP0103649A3 (es)
ID (1) ID28650A (es)
IL (2) IL142112A0 (es)
MX (1) MXPA01003340A (es)
NO (1) NO330234B1 (es)
NZ (1) NZ510446A (es)
PL (1) PL200693B1 (es)
PT (1) PT1117420E (es)
RU (1) RU2214270C2 (es)
SI (1) SI1117420T1 (es)
TR (1) TR200100887T2 (es)
WO (1) WO2000018423A1 (es)
ZA (1) ZA200102452B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
SE0104462D0 (sv) 2001-12-29 2001-12-29 Carlbiotech Ltd As Peptide purifcation (Peptidrening)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
US4659969A (en) * 1984-08-09 1987-04-21 Synektron Corporation Variable reluctance actuator having position sensing and control
EP0308181A1 (en) * 1987-09-14 1989-03-22 Novo Nordisk A/S Trans-mucosal delivery formulations and a method for preparation thereof
SI9300470A (en) * 1993-09-10 1995-04-30 Lek Tovarna Farmacevtskih Inclusion complexes of optically active and racemic ibuproxan with cyclodextrin derivates,process for their preparation,pharmaceutical preparations comprising the same and their use
JPH11292787A (ja) * 1995-08-15 1999-10-26 Asahi Chem Ind Co Ltd 生理活性ペプチドを含有する経粘膜投与製剤
ATE272394T1 (de) * 1996-10-31 2004-08-15 Takeda Chemical Industries Ltd Zubereitung mit verzögerter freisetzung
EP0842946A1 (en) * 1996-11-14 1998-05-20 Laboratoire Theramex S.A. Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
ATE218358T1 (de) 2002-06-15
CZ302343B6 (cs) 2011-03-23
WO2000018423A1 (en) 2000-04-06
ZA200102452B (en) 2002-03-26
NZ510446A (en) 2003-01-31
EE04872B1 (et) 2007-08-15
AR023056A1 (es) 2002-09-04
DK1117420T3 (da) 2002-09-16
AU756233B2 (en) 2003-01-09
SI1117420T1 (en) 2002-12-31
ES2178478T3 (es) 2002-12-16
KR20010075255A (ko) 2001-08-09
DE69901721T2 (de) 2003-01-09
EP0998940A1 (en) 2000-05-10
CN1324241A (zh) 2001-11-28
PL200693B1 (pl) 2009-01-30
DE69901721D1 (de) 2002-07-11
IL142112A0 (en) 2002-03-10
TR200100887T2 (tr) 2001-10-22
IL142112A (en) 2006-10-31
NO330234B1 (no) 2011-03-07
KR100652457B1 (ko) 2006-11-30
JP4485060B2 (ja) 2010-06-16
HK1042047B (zh) 2005-12-16
CA2344470C (en) 2009-01-06
EE200100196A (et) 2002-06-17
PT1117420E (pt) 2002-10-31
NO20011576L (no) 2001-03-28
RU2214270C2 (ru) 2003-10-20
HUP0103649A3 (en) 2002-05-28
PL346939A1 (en) 2002-03-11
AU6199999A (en) 2000-04-17
EP1117420A1 (en) 2001-07-25
CZ20011173A3 (cs) 2001-09-12
JP2002525336A (ja) 2002-08-13
HUP0103649A2 (hu) 2002-02-28
CA2344470A1 (en) 2000-04-06
NO20011576D0 (no) 2001-03-28
CN1200727C (zh) 2005-05-11
EP1117420B1 (en) 2002-06-05
BR9914125A (pt) 2001-06-19
ID28650A (id) 2001-06-21

Similar Documents

Publication Publication Date Title
BG105564A (en) Galantamine-containing composition with controlled release
TR200002299T2 (tr) Epotilon kompozisyonları.
BR0015188A (pt) Composições farmacêuticas
IL133397A0 (en) Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
BG103930A (en) Eletriptan hemisulphate and caffeine containing pharmaceutical compositions
BG103882A (en) Voriconazol-containing pharmaceutical compositions
IT1255258B (it) Composizioni farmaceutiche per l'applicazione per via nasale.
BG102526A (en) Flurbiprophene-containing pharmaceutical compositions
PL334566A1 (en) Treatment of sclerosis multiplex by oral and inhalatory administration of a copolymer-1
MY129572A (en) Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor
NZ511085A (en) Oral pharmaceutical compositions containing buprenorphin
WO1998019697A3 (en) Novel pharmaceutical compositions
PL346764A1 (en) New oral formulation for 5-ht4
MXPA01003340A (es) Composiciones farmaceuticas en base a alfa-ciclodextrina para la administracion por via oral de analogos de lh-rh.
GEP20043377B (en) Pharmaceutical Complex
BG103412A (en) Stabilized pharmaceutical compositions based on chinupristine and dalfopristine and their preparation
ATE204286T1 (de) Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge
GR1002385B (el) Καθαρη μορφη στρεπτογραμινων, παρασκευη αυτης και φαρμακευτικες συνθεσεις που την περιεχουν.
AP1734A (en) Crystalline forms of 1S-[1alpha(2S*,3*), 9 alpha]-6, 10-dioxo-N-(2-ethoxy-5- oxo-tetrahydro-3-furanyl)-9-[[(isoquinolyl) carbonyl]-amino] octahydro-6H-piridazino[1,2-A][1,2] diazepin- 1-carboxamide.
TW429144B (en) The pharmaceutical composition comprising the Con.A-Maltose complex and vehicle for oral use

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees